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ABSTRACT: Copper oxide nanoparticles (CuONPs) have been widely recognized as good antimicrobial agents but are heavily 
regulated due to environmental concerns of their post use. In this work, we have developed and tested a novel type of formulation for 
copper oxide (CuONPs) which have been functionalized with (3-Glycidyloxypropyl)trimethoxysilane (GLYMO) to allow further 
covalent coupling of 4-Hydroxyphenylboronic acid (4-HPBA). As the boronic acid (BA) groups on the surface of 
CuONPs/GLYMO/4-HPBA can form reversible covalent bonds with the diols groups of glycoproteins on the bacterial cell surface, 
they can strongly bind to the cells walls resulting in a very strong enhancement of their antibacterial action which is not based on 
electrostatic adhesion. SEM and TEM imaging revealed that 4-HPBA-functionalized nanoparticles could accumulate more on the 
cell surface than non-functionalized ones. We demonstrate that the CuONPs with boronic acid surface functionality are far superior 
antibacterial agents compared to bare CuONPs. Our results showed that, the antibacterial impact of the 4-HPBA functionalized 
CuONPs on Rhodococcus rhodochrous (R. rhodochrous) and Escherichia coli (E.coli) is one order of magnitude higher than that of 
bare CuONPs or CuONPs/GLYMO. We also observed a marked increase of the 4-HPBA functionalized CuONPs antibacterial action 
on these microorganisms at shorter incubation times compared with the bare CuONPs at the same conditions. Significantly, we show 
that the cytotoxicity of CuONPs functionalized with 4-HPBA as an outer layer can be controlled by the concentration of glucose in 
the media and that the effect is reversible as glucose competes with the sugar residues on the bacterial cell walls for the BA-groups 
on the CuONPs. Our experiments with human keratinocyte cell line exposure to CuONPs/GLYMO/4-HPBA indicated lack of 
measurable cytotoxicity at particle concentration which are effective as antibacterial agent for both R. rhodochrous and E.coli. We 
envisage that formulations of CuONPs/GLYMO/4-HPBA can be used to drastically reduce the overall CuO concentration in 
antimicrobial formulations while strongly increasing their efficiency.  
 
INTRODUCTION 
Spreading of antimicrobial resistance among common bacterial 
pathogens, bacterial infections, including antibiotic‐resistant 
infections, have recently drawn much attention.1 A range of 
colloidal particles are being extensively studied in various 
antimicrobial applications due to their small size to volume ratio 
and ability to exhibit a wide spectrum of antibacterial action.2-5 
Antibacterial NPs could bypass the increasing rates of antibiotic 
resistance by attacking and destroying the bacteria in other 
ways.6 Surface functionalization of nanoparticles is vital for 
controlling their properties and interactions with molecules and 
ligands of relevance for biomedical applications, in addition to 
their susceptibility to undergo a transformation in 
environmental and biological systems.45,46 Considerable efforts 
have been devoted to the development of surface modifiers that 
can offer not only stability but also better control of the 
interaction between nanoparticles and biological membranes in 
order to obtain more biocompatible materials.47 For example, 
Al-Awady et al.44 produced polyelectrolyte-coated titania 
nanoparticles with up to 4 layers of polyelectrolytes of 
alternating charge (PSS and PAH) using the layer-by-layer 
technique. They showed that the antimicrobial properties of 
polyelectrolyte-coated nanoparticles alternate with the surface 
charge for the particles with cationic outer layer (or bare 
nanoparticles) being much more effective antimicrobials than 
the ones with an outer layer of anionic polyelectrolyte. The 
anionic nanoparticles (NPs/PSS and NPs/PSS/PAH/PSS) 
showed much lower activity towards than the cationic ones, 
NPs/PSS/PAH and the bare NPs, respectively. These authors 
suggested that the decrease of antimicrobial action can be 
explained by the poor adhesion of the anionic nanoparticles 
(NPs/PSS and NPs/PSS/PAH/PSS) to the cell walls due to their 
electrostatic repulsion. In contrary, the enhancement of the 
antimicrobial effect for cationic nanoparticles (bare NPs and 
NPs/PSS/PAH) is due to the amplification of the particle-cell 
electrostatically driven adhesion.2,35 Perreault and co-workers 




acrylate) CuONPs showed increased cellular uptake and 
toxicity in the green alga C. reinhardtii. The ascorbate and 
citrate surface layers are well known for their anti-oxidant 
properties and are used as reducing agents as well as negatively 




Figure 1. The perceived attachment mechanisms of CuONPs to the bacterial cell membranes. (A) Electrostatic attraction between 
bare CuONPs and the cells; (B) covalent bonding between CuONPs/GLYMO/4-HPBA and the cells. (C) The interaction between the 
CuONPs with boronic acid surface functionality and the sugar groups on the surface of the bacterial cell wall. 
 
Líbalová et al. have evaluated the cytotoxicity of a panel of 
CuONPs with various surface modifications such as cationic 
polyethylenimine (PEI), neutral polyvinylpyrrolidone (PVP), 
sodium ascorbate (ASC) and anionic sodium citrate (CIT), 
versus the pristine bare CuONPs, using a murine macrophage 
cell line. The results from their work suggest that the PEI-coated 
CuONPs were found to be the most cytotoxic. Líbalová et al. 
have also reported that the ascorbate-coated CuONPs, which 
were found to be the least cytotoxic, produced lower levels of 
ROS in comparison to bare nanoparticles.46 
CuONPs have been widely used as a dopant for 
semiconductors, chemical sensors, supported heterogeneous 
nano-catalysts, coating material and in anti-cancer treatments 
but their functional properties have been proven essential for 
their applications in biological research.7,8 Lazary and co-
workers have stated that CuONPs have been widely used in 
hospitals as anti-microbial agents due to their ability to kill 
more than 99.9% of both Gram-negative and Gram-positive 
bacteria within 2 hours of treatment of various surfaces. It has 
been found that the use of CuO in this way has radically 
decreased the occurrence of hospital-acquired infections and 
the costs associated with health care. A non-intravenous 
approach to utilizing CuONPs in bed sheets is a very exciting 
innovation as the particles can decrease microbial attachment 
and therefore limit hospital acquired infections.9 By 
synthesizing a hybrid inorganic/organic species in the form of a 
Cu-chitosan nanoparticle, Usman et al.10 have found that their 
antimicrobial action is highly effective when the coated 
particles have a size range of 2–350 nm. The same research 
team has evaluated the antibacterial and antifungal activities of 
these nanoparticles on different microorganisms, including 
methicillin-resistant Staphylococcus aureus, Salmonella 
choleraesuis, Candida albicans, Pseudomonas aeruginosa, and 
Bacillus subtilis. The results from their work have shown that 
the highly effective Cu-chitosan particles are very active as 
antimicrobial agents in anaerobic conditions. Note that Cu 
nanoparticles have the ability to rapidly oxidize, which limits 
their applications as antimicrobials when used in aerobic 
conditions.10,11 Katwal and others have developed a new 
CuONPs preparation route by using electrochemical methods 
and demonstrated that they can control the CuONPs 
morphologies. 12 CuO particles can be produced in various 
shapes and sizes, and can provide enhanced antibacterial 
activity against several pathogenic strains. Mahapatra et al.11 
tested the antibacterial action of CuONPs towards Klebsiella 
pneumoniae, Salmonella paratyphi, Shigella strains and 
Pseudomonas aeruginosa and showed that the nanoparticles 
have been efficient against these bacteria. They envisaged that 
CuONPs can cross through the bacterial cell membrane and 
affect vital enzymes in the bacteria cytoplasm leading to their 
death. It has also been shown that CuONPs are not cytotoxic on 
some human cells (e.g. HeLa cell line). Azam et al. 13 have also 
reported that the activity of CuO based nanoparticles is 
dependent on their particle size when used as an antibacterial 
agent. In their study, they examined two Gram-negative 
bacteria (E. coli and P. aeruginosa) and two Gram-positive 
bacteria (B. subtilis and S. aureus). It was found that CuONPs 
exhibited inhibitory effects towards both groups of bacteria, 
which clearly depended on their stability, particle size and 
concentration when incubated with the bacterial culture. They 
concluded that the CuONPs can limit the bacterial growth by 
interacting with nanometric pores that exist on the cell 
membranes of most microorganisms. Ahamed and co-workers 




antimicrobial action towards various bacterial strains 
(Klebsiella pneumoniae, Pseudomonas aeruginosa, 
Escherichia coli, Enterococcus faecalis, Shigella flexneri, 
Salmonella typhimurium, Staphylococcus aureus, and Proteus 
vulgaris). Escherichia coli and Enterococcus faecalis showed 
the highest sensitivity to CuONPs while Klebsiella pneumoniae 
was resistant to this treatment.2,7,8 Note that the bare CuONPs 
are cationic at neutral pH and can adhere to the negatively 




Figure 2. The schematic of the surface functionalization of CuONPs with GLYMO and 4-HPBA. 
 
The average size of CuONPs is also essential for their potential 
antimicrobial activity, as smaller nanoparticles have higher 
portability and ability to potentially penetrate and relocate 
between the bacterial cell compartments. This makes them very 
effective antimicrobial agents. However, electrostatic adhesion 
can be easily disabled by the presence of another type of anionic 
substances in the solution, e.g. organic acids, albumins, 
surfactants, polymers and others. It impacts the nanoparticle 
interactions with different biomolecules, for example, 
carbohydrates and proteins which can be adsorbed on the 
particles and form a corona of different surface properties to 
that of the original nanoparticles. This is the likely reason why 
CuONPs can quickly lose their antimicrobial activity in 
biological fluids as well as in formulations that contain anionic 
polyelectrolytes and surfactants.  
Here we engineered CuONPs with boronic acid surface 
functionality in an attempt to design a non-electrostatic 
mechanism for their attachment to the bacteria which was 
expected to amplify their accumulation on the cell walls despite 
the presence of other anionic species. This is shown 
schematically in Figure 1. Our idea here is to introduce boronic 
acid (BA) surface groups on the CuONPs which are able to 
covalently bind to various glycoproteins and carbohydrates that 
are abundant on the bacterial cell walls.  
Boronic acid has been used before in chemosensor applications 
due to its high sensitivity for sugar determination.14 An 
attractive feature of the BA surface functionality that makes it 
very effective for biomedical applications is their perceived 
absence of toxicity15 despite its ability to form reversible 
covalent complexes with diols.16,17 The binding of BA to sugars 
is very sensitive to the sugar concentration, however, it is 
undiscriminating and will therefore bind to any diol containing 
compounds.18 BA has also been discussed as a promising tools 
for the quantification of the total content of bacteria.19-21 BA 
surface groups can covalently bind to saccharides and form 
boronic esters.22-24  
We used R. rhodochrous and E.coli as model bacteria species 
to examine the antibacterial activity of the 4-HPBA 
functionalized CuONPs. The current work was carried out with 
CuONPs, CuONPs/GLYMO and CuONPs/GLYMO/4-HPBA 
to investigate the impact of (i) the nanoparticle concentration, 
and (ii) the zeta potential and particle size on the viability of R. 
rhodochrous and E.coli at different exposure times. The novelty 
of our work is that the antibacterial activity of CuONPs 
functionalized with 4-HPBA is not based on electrostatic 
adhesion to the bacterial cells and therefore could potentially be 
used in complex biological environment. Significantly, the 
functionalization of the CuONPs with 4-HPBA groups as an 
outer monolayer should lead to their covalent attachment on the 
sugar (OH) groups on the membrane surface, thus bringing the 
CuONPs in very close proximity to the bacterial cell membrane 
and increasing their efficiency (Figure 1B and 1C). We also 
examined the toxicity of both bare CuONPs and functionalized 
CuONPs on human keratinocytes.  
MATERIALS AND METHODS 
Materials 
We used copper (II) chloride (99%, Sigma Aldrich) as a 
precursor in the synthesis of CuONPs by the direct precipitation 
method. Sodium hydroxide (99.6%, Fisher, UK) was used as a 
precipitating agent to synthesise CuONPs. (3-
glycidyloxypropyl) trimethoxysilane (GLYMO) and 4-
hydroxyphenylboronic acid (4-HPBA) were purchased from 
Sigma Aldrich. BacTiter-Glo (BTG) microbial cell viability 




from Thermofisher (Invitrogen MAX Efficiency DH10B) 
was kindly provided for our antibacterial tests by Prof J. 
Rotchell’s group at the University of Hull, UK. R. rhodochrous 
was supplied by Blades Biological Ltd., UK. Deionized water 
purified by reverse osmosis and ion exchange with a Milli-Q 
water system (Millipore, UK) was used in all our studies. Its 
surface tension was 71.9 mNm-1 at 25°C, with measured 
resistivity more than 18 MΩ cm-1. 
 
Figure 3. Plots of (A) particle size and (B) zeta potential 
distribution of CuONPs produced by annealing at 100 °C. The 
size and zeta potential of CuONPs was measured utilizing the 
Malvern Zetasizer Nano ZL at room temperature with the 
average data of three runs. (C) XRD pattern of CuONPs 
annealed at 100 °C. The largest peak in the XRD results was 




Synthesis of CuONPs. In first stage of the preparation, 3.0 g 
of copper (II) chloride (CuCl2) was dissolved in 160 mL of 
ethanol. 1.8 g of sodium hydroxide (NaOH) was dissolved in 50 
mL ethanol. The NaOH solution was added dropwise to CuCl2 
solution under constant stirring at room temperature. During the 
course of the reaction, the color of the solution turned from 
green to greenish blue and lastly to black. This black precipitate 
was copper hydroxide, Cu(OH)2 (see Figure S1) which was 
centrifuged, washed with ethanol and deionized water, and 
dried at 60 oC in the electric furnace. In order to produce 
CuONPs, the sample of dry Cu(OH)2 was annealed at different 
temperatures, 100 oC, 200 oC, 300 oC, 400 oC, 500 oC and 600 
oC (see Figures S2 and S3) followed by grinding to obtain CuO 
in powdered form.25 CuONPs were produced by dispersing CuO 
in Milli-Q water at pH 6 via a sonication (Branson 450, 5 mm 
tip, 400 W maximum power) at 40% of the maximum power for 
10 minutes (2 s ON - 2 s OFF pulse time).  
Surface Functionalization of CuONPs by GLYMO and 4-
HPBA. A sample of 0.1 g of CuONPs was dispersed into 
deionized water (100 mL, pH 6–6.5). The suspension was 
stirred for 1 hour and 0.1 wt% of GLYMO were added. The 
reaction mixture was stirred for a further 24 hours, then the 
unreacted GLYMO was removed by centrifugation and 
washing with deionized water three times. The process is 
analogous to the APTES functionalization of other inorganic 
nanoparticles26 but in our case GLYMO brings epoxy-ring as a 
terminal group. This functionality has not been reported before 
for CuONPs. The GLYMO- functionalized CuONPs pellet was 
then re-dispersed in 100 mL of deionized water and mixed drop-
wise with 0.1 g of 4-HPBA dissolved in 100 mL of ethanol 
solution. The mixture was shaken for 2 hours, then washed and 
centrifuged three times with ethanol at 10000 rpm for 30 
minutes. The CuONPs/GLYMO/4-HPBA produced were 
finally re-dispersed in 100 mL of deionized water.27-29 The 
chemistry of the process of surface functionalization of 
CuONPs with phenyl boronic acid is shown in Figure 2.  
Characterization of the Surface Functionalized CuONPs. 
The particle size and the zeta potential of the surface 
functionalized CuONPs (with GLYMO and 4-HPBA) was 
examined by dynamic light scattering (DLS) using the Malvern 
Zetasizer Nano ZL instrument. The zeta potential values of the 
surface functionalized CuONPs were determined after 
dispersing the CuONPs samples in deionized water using an 
ultrasonic probe. After that, a range of CuONPs suspensions 
with pH from 3 to 12 was made by using 0.1 M HCl and 0.1 M 
NaOH and adding two drops of 0.01 M NaCl into each sample 
(10 mL). All measurements have been done at room 
temperature and the results reported are an average of 3 runs.  
Antibacterial Activity of Bare and Surface 
Functionalized CuONPs on E. coli and R. rhodochrous. 10 
mL of the bacteria culture was centrifuged and washed three 
times with deionized water for 4 minutes at 4000 rpm, and re-
dispersed in 100 mL deionized water. Then, 5 mL of the washed 
bacteria were incubated with a series of 5 mL aliquots of the 
CuONPs suspension at various particles concentrations. The 
number of bacteria was measured directly after removing the 
excess nanoparticles from the bacteria dispersion. Then, 1 mL 
of each bacteria suspension was washed and re-suspended in 1 
mL deionized water. 100 μL aliquot of the washed bacteria 
suspension was then incubated with 100 μL of BTG reagent in 
a white opaque 96-well microplate with solid flat bottom, and 
after that shaken for 30 seconds, and incubated at 30 oC for 5 
minutes. The relative luminance was measured as a function of 
the incubation time and used to calculate the fraction of viable 
bacteria upon exposure to various concentrations of CuONPs. 
We did the same experiments with CuONPs functionalized with 
GLYMO as well as ones functionalized with GLYMO and 4-
HPBA at various particle concentrations. 
Colony Forming Units assessment for antimicrobial 
assay. The bacteria were grown overnight in sterilized LB 
medium at 37 oC to produce viable colonies. Bacterial cells 
were pelleted down by centrifugation at 5000 rpm for 10 
minutes followed by washing (twice) with 0.85 w/v% serial 
saline until an optical density of 0.08-0.12 at 625 nm was 
obtained using a spectrophotometer. These adjusted bacterial 




starting concentrations between 5 × 105 – 1 × 106 colony 
forming units per mL (CFU/mL). Then flasks 250 mL 
containing LB medium 100 mL with different concentrations of 
the bare CuONPs and surface functionalized of CuONPs with 
GLYMO and 4-HPBA were inoculated with an equal volume 
of the bacterial suspension. Flasks containing bacterial cells and 
media without nanoparticles were used as control. All the flasks 
were incubated for 10 min, 1 hour and 6 hours in a shaker at 37 
oC with 140 rpm. After that, the serial dilutions were made of 
all the treated samples including control and 100 µL of each 
were homogeneously spread on LB agar plates for colony 
forming unit (CFU). The growth rate of bacterial cells 
interacting with the nanoparticles was determined from a plot 
of the CFU/mL versus concentrations. The time-kill assay was 
repeated in three independent experiments 
Zeta Potential Measurements of E.coli after Treatment 
with CuONPs. The changes in the surface charge of the 
bacteria after incubation with the bare and the surface modified 
CuONPs were determined by a Zetasizer nano ZL instrument 
(Malvern, UK) at nanoparticle concentrations of 0, 5, 10, 15, 
20, and 25 µg mL-1. Equal aliquots of the cell culture was used 
to measure the average zeta potential value of the bacteria after 




Figure 4. Zeta potential and particle diameter of bare CuONPs 
versus pH of the aqueous suspension. 
Figure 5. Zeta potential and hydrodynamic diameter of the 
bare and surface modified CuONPs with GLYMO and 4-
HPBA, measured at room temperature at pH 6 (error bars are 
standard deviations). 
 
SEM and TEM Sample Preparation Protocol for E.coli 
and R. rhodochrous after Exposure to HPBA-
Functionalized CuONPs. After incubation with the HPBA-
surface modified CuONPs, the E.coli and R. rhodochrous were 
fixed with 2.5% glutaraldehyde at room temperature for two 
hours in 0.1M cacodylate buffer pH 7.2. These samples were 
then post-fixed in 1% osmium tetroxide for one hour, and 
dehydrated in a range of ethanol-water mixtures with increasing 
ethanol content from 50 vol% up to 100 vol% followed by 
critical point drying. After incubation with CuONPs, the 
bacterial cells were prepared for TEM imaging using the 
following procedure. The bacteria were washed with deionized 
water to remove the excess of CuONPs at 500 rpm and then 
fixed in 2 wt% glutaraldehyde for one hour at room temperature 
followed by treatment with 1 wt% osmium tetroxide for one 
hour. Then, the samples were incubated for one hour with 2.5 
% uranyl acetate and washed with aqueous ethanol solutions of 






Figure 6. The FTIR spectra of (A) pure GLYMO, (B) pure 
4-HPBA and (C) the bare and functionalized CuONPs. 
 
After standard dehydration, the bacterial samples were 
embedded in fresh epoxy/Araldite at 60 oC for 2 days, left for 2 
days at room temperature and sectioned with an ultra-
microtome. Bacteria samples before and after the nanoparticle 
treatment were imaged by SEM and TEM.  
Cytotoxicity Assay of Bare and Surface Functionalized 
CuONPs on HaCaT Cells.  
HaCaT cell line culture (immortalized human keratinocytes) 
was kindly provided by the Skin Research Group at St James 
University Hospital at Leeds. The cells were cultured in high-
glucose DMEM media supplemented with 10% Fetal Bovine 
Serum (FBS, Labtech, UK) and 1% antibiotics (Penicillin 
Streptomycin, Lonza, UK) and placed in an incubator (37°C, 
5% CO2). After reaching 70% confluence, HaCaT cells were 
carefully washed with PBS for 10 seconds then incubated with 
0.25% Trypsin-EDTA (1X, Lonza, UK) to detach the cells from 
their support after 5 minutes. Its action was neutralized by 
adding complete DMEM medium before a centrifugation at 
400×g for 4 minutes. An 25 mL aliquot  of the HaCaT cells 
culture (~75000 cells mL-1) were washed three times from the 
culture media via centrifuged, and re-dispersed with 25 mL 
PBS. Then, 2.5 mL aliquots of this HaCaT cells suspension 
were incubated with a series of 2.5 mL aliquots of aqueous 
dispersions of bare and surface functionalized CuONPs at 
different concentrations. Likewise, a control sample of the 
HaCaT cells was treated at the similar conditions without 
exposure to any nanoparticles. After that, 1 mL of the solution 
HaCaT was taken from each addressed sample with 
nanoparticles, washed with PBS to remove the excess of 
nanoparticles via centrifuged at 400×g for 4 minutes. The 
HaCaT was re-suspended in 1 mL of PBS, then two drops of 
FDA solution in acetone was added to each sample and mixed 
together for 15 minutes followed by triple washing with PBS by 
centrifugation at 400×g for 4 minutes. Finally, a microplate 
reader was utilized to assay the HaCaT cell viability. 
RESULTS AND DISCUSSION 
Characterization of CuONPs. We studied the mean particle 
hydrodynamic diameter and zeta potential of bare and 
functionalized CuONPs. The results for the non-functionalized 
particles are presented in Figures S4 and S5 (ESI). The bare 
CuONPs average particle hydrodynamic diameter was about 93 
nm while their average zeta potential was around +37 mV, i.e. 
the non-functionalized (bare) CuO nanoparticles are cationic at 
pH 6 (see Figures 3A and 3B). Since the CuONPs are 
photoactive, there was a concern that the GLYMO/HPBA 
functionality can potentially be affected by oxidation under the 
action of UV light. In order to check the stability of this coating 
against oxidation, we measured periodically the zeta potential 
of the CuONPs/GLYMO/4-HPBA over the course of 3 days 






Figure 7. Comparison of the E.coli viability at various concentrations of the bare CuONPs (A - C), and surface functionalized of 
CuONPs with GLYMO (D - F) and 4-HPBA (G - I) in dark, visible and UV light conditions at different incubation times (shown).  





Figure 8. TEM images of E.coli at different magnifications: (A) before treatment, and (B, C) after treatment with 25 µg mL-1 bare 
CuONPs, (D) 25 µg mL-1 CuONPs/GLYMO and (E, F) 25 µg mL-1 CuONPs/GLYMO/4-HPBA, all for 6 hours. 
 
The results, presented in Figure S7 (ESI) indicate that the zeta-
potential of the functionalized CuONPs does not change, i.e. the 
coating is not prone to oxidation at these conditions and hence 
the particles preserve their functionality and antibacterial 
action. Figure 3C shows XRD pattern of CuONPs produced by 
the direct precipitation method and calcinated at 100 oC. The 
diffraction peaks agree very well with the hexagonal structure 
of CuO according to the Joint Committee on Powder 
Diffraction Standards (JCPDS no.01-077-7716). No apparent 
impurities were detected, suggesting that CuONPs of high 
purity were prepared. The average crystal size of CuONPs 
calculated from XRD data using the Scherrer equation was 
about 13 nm, i.e. much smaller than the hydrodynamic 
diameters of the CuONPs dispersed in deionized water. This 
indicates that the CuONPs in aqueous dispersions are 
aggregates of smaller crystallites. Figure 3D shows the EDX 
spectrum of CuONPs annealed at 100 oC. The results confirm 
the presence of only copper (Cu) and oxygen (O) in the 
CuONPs samples and the data indicate that the nanoparticles 
were nearly stoichiometric with 73.3 wt % Cu (0.804 keV) and 
13.7 wt % O (0.525 keV), respectively. There was no indication 
of any other elemental impurities in the EDX spectra, i.e. the 
copper-to-oxygen atomic ratio was 1:1 in the CuONPs, which 
is in agreement with the literature.30,31  
Characterization of the CuONPs Surface Functionalized 
of with GLYMO and 4-HPBA. The zeta potential of bare 
CuONPs as a function of pH is shown in Figure 4. The 
isoelectric point (IEP) of the CuONPs (corresponding to the pH 
where the CuONPs have zero zeta potential) is at pH 9. We 
found that at pH values above the IEP, the CuONPs partially 
lost their colloid stability and formed larger aggregates (500 nm 
or bigger). To avoid the ambiguity related to the particle surface 
charge being influenced by pH, we carried the antibacterial tests 
at pH between 5 and 6 (away from the IEP) to ensure that the 
particle size is around 100 nm. The zeta potentials and 
hydrodynamic diameters of bare and functionalized CuONPs 
determined at pH 6 are compared in Figure 5. One can see that 
the bare CuONPs dispersed in deionized water have the smallest 
hydrodynamic diameter (94±3 nm), while the diameter of 
surface-modified CuONPs varied between 106±6 nm (for 
CuONPs/GLYMO) and 121±4 nm (for CuONPs/GLYMO/4-
HPBA).The zeta potential of bare CuONPs was positive while 
the two types of surface-modified CuONPs had small but 
negative zeta potential, ranging from around -3±2 mV 
(CuONPs/GLYMO) to -10±2 mV (CuONPs/GLYMO/4-
HPBA) (see Figure 5). The efficiency of the alkoxysilane-
mediated functionalization with GLYMO (and latter with 4-
HPBA) on CuONPs was examined by FTIR. The OH groups on 
the surface of the CuO nanoparticles are the reactive sites for 
the reaction with alkoxy silane groups of GLYMO. Figures 6A, 
6B and 6C show normalized FTIR spectra of the bare CuONPs 
and those, surface modified with GLYMO or GLYMO/4-
HPBA. In the spectra of all CuONPs, the broad band between 
400 and 800 cm-1 corresponds to Cu-O-Cu. GLYMO contains 
two functional groups: epoxy and methoxysilyl, which can both 
hydrolyze and condensate. One can see that the epoxy band in 
FTIR spectra (Figure 6A) is preserved, while the intensity of Si-
O-Me band is decreased. Moreover, the two bands of OH 
groups appear at ~3300 and ~1640 cm-1 because of the 







Figure 9. SEM images of E.coli after being incubated for 6 hours with bare CuONPs and CuONPs functionalized with GLYMO or 
4-HPBA: (A) E.coli before treatment, (B) E.coli incubated with 25 µg mL-1 CuONPs, (C and D) E.coli incubated with 25 µg mL-1 
CuONPs/ GLYMO at different magnifications. (E and F) E.coli incubated with 25 µg mL-1 CuONPs/GLYMO/4-HPBA at different 
magnifications. Note the extensive build-up of (B) CuONPs and (E,F) CuONPs/GLYMO/4-HPBA on the E. coli cell walls. 
 
Also a peak at 1050 cm-1 appears, which can be assigned to the 
formation of Si-O-Si groups. The comparison of the FTIR 
spectra of the bare and functionalized CuONPs samples show 
some new characteristic absorption peaks. 
Figure 6C (CuONPs/GLYMO) shows a peak at ~1200 cm-1 
which refers to Si-O-Me groups.32 In the FTIR spectrum of the 
CuONPs/GLYMO/4-HPBA, the peak at about 3300 cm-1 could 
be attributed to the stretching vibration of O–H groups. The 
peaks at ~2500 cm-1 were assigned to the stretching and bending 
vibrations of C–H groups. The bending of the aromatic C=C 
groups could be also observed at 1490–1650 cm-1. The sharp 
peaks at around 1343 cm-1 and 1090 cm-1 could be assigned to 
the stretching vibrations B–O and C–B groups (Figure 6C).33,34  
Antibacterial Activity of Surface Functionalized CuONPs 
against E.coli. We examined the antibacterial activity of 
CuONPs surface functionalized with GLYMO and 4-HPBA on 
E.coli at pH 6. Although the bare CuONPs are cationic below 
pH 9, their functionalization with GLYMO resulted in weakly 
negatively charged CuONPs/GLYMO. Further 
functionalization with 4-HPBA also yielded negatively charged 
CuONPs/GLYMO/4-HPBA. The E.coli cells were extracted 
from the growth media and redispersed in deionized water and 
aliquots of this E. coli cultures were incubated with fixed 
concentration of the nanoparticles (i) under UV light, (ii) under 
visible light and (iii) in dark conditions.  
The E.coli culture was incubated with CuONPs at different 
particle concentrations (0, 5, 10, 15, 20 and 25 µg mL-1) for 
various durations (10 minutes, 1 hour and 6 hours). The 
viability of E.coli after this treatment in dark, visible and UV 
light conditions is showed in Figure 7 at various incubation 
times. It was noticed that immediately after exposure (10 
minutes), the fraction of viable E.coli declined with in the 
presence of bare CuONPs and CuONPs/GLYMO/4-HPBA 
concentrations over 5 µg mL-1. After 1 hour of such treatment 
in dark, visible light and UV light conditions, the viability of 
E.coli in the presence of nanoparticles was further reduced. 
After 6 hours incubation with 5-25 µg mL-1 
CuONPs/GLYMO/4-HPBA, all E.coli lost completely their 
viability. Figures 7A, 7B and 7C show that the CuONPs had 
excellent antibacterial activity towards E. coli. There are many 
various mechanisms discussed in the literature about how 
CuONPs kill E.coli and their antibacterial action might be a 
mixture of all of them. One mechanism is based on the 
photoactive nature of these nanoparticles which in the presence 
of oxygen from air and visible or UV light, form reactive 
oxygen species (ROS) which are free radicals and lead to 
peroxidation of lipids from the bacterial cell membrane. 2,3,5,35 
The cell wall of E.coli is negatively charged while the un-
functionalized (bare) CuONPs is positively charged (below pH 
9). Therefore, the un-functionalized CuONPs were able to 
electrostatically adhere on the bacterial cell surface which led 
to damage of their cell membrane. When the free CuONPs 
attach to the cell, the ROS created locally can interact directly 
with the cell organelles which can amplify the cell damage. The 
ROS generation begins of a chain of free radical reactions inside 
the bacteria. Lipid peroxidation is a type of oxidative stress for 





Figure 10. Cell viability of R. rhodochrous upon incubation of bare and surface functionalized of CuONPs of different particle 
concentrations (0, 5, 10, 15, 20, 25 and 250 µg mL-1) in dark, visible and UV light conditions. The R. rhodochrous cells were incubated 
with: (A-C) bare CuONPs; (D-F) CuONPs/GLYMO and (G-I) CuONPs/GLYMO/4-HPBA at 10 min, 1 hour and 6 hours exposure 
times. 
 
However, Figure 7 shows that the antibacterial activity of 25 µg 
mL-1 CuONPs towards E.coli under UV light for 1 hour is 
slightly higher than that under dark conditions. This suggests 
that the ROS generation under UV light has only a minor effect 
on the antibacterial action of CuONPs.  
Another possible antimicrobial mechanism is the release of free 
Cu2+ ions from the CuONPs which may interfere with the cell 
membrane proteins. However, the concentration of free Cu2+ 
ions in the aqueous solution around the CuONPs is negligible 
due to its very small solubility. The values of the CuO solubility 
varies with pH but in pure water it is approximately 3×10-5 M. 
36 This is not sufficient to explain the antimicrobial effect of 
CuONPs, which increases with their concentration, while the 
CuO solubility is constant at fixed pH and temperature).Our 
working hypothesis is that the strong antimicrobial action can 
be explained by the direct attraction of the cationic CuONPs 
with the anionic bacterial cell walls. As CuONPs are aggregates 
of rough surface, a likely explanation is that their adhesion to 
the membrane causes its rupture and this is the main 







Figure 11. TEM images of R. rhodochrous after being incubated for 6 hours into 25 µg mL-1 bare and surface functionalized of 
CuONPs: (A) an untreated sample without CuONPs (B) R. rhodochrous incubated with CuONPs (C) R. rhodochrous incubated with 
CuONPs/GLYMO (D) R. rhodochrous incubated with CuONPs/GLYMO/4-HPBA.  
 
We also found that the antibacterial effect of CuONPs/GLYMO 
(Figure 7D, 7E and 7F) is lower than the one of the bare 
CuONPs and CuONPs/GLYMO/4-HPBA. Note that 
CuONP/GLYMO are anionic at this pH and therefore lack 
electrostatic adhesion to the bacterial cell walls. Nevertheless, 
the introduction of a secondary functionalization of these 
anionic nanoparticles by conjugation of 4-HPBA made the 
produced CuONPs/GLYMO/4-HPBA much more effective 
against E.coli than the bare CuONPs. The later effect can be 
seen in Figure 7G, 7H and 7I. It is interesting that at lower 
CuONPs/GLYMO/4-HPBA concentrations (5 µg mL-1) these 
anionic particles are several times more effective than the bare 
CuONPs and CuONPs/GLYMO irrespectively of the time of 
exposure in dark, visible or UV light conditions. These results 
require some discussion with respect to the possible factors that 
may contribute to the antibacterial activity of the 
CuONPs/GLYMO/4-HPBA. It has been shown that ligands 
with BA-functionality can covalently bind with diol 
compounds, like nucleotides, glycate-protein and saccharide.22, 
23, 37 Note that despite their negative surface charge, the anionic 
nanoparticles CuONPs/GLYMO/4-HPBA are showing a very 
significant antibacterial effect on E.coli even at lower particle 
concentrations than the bare CuONPs due to their covalent 
binding to the bacterial membrane. E. coli is surrounded by an 
outer membrane containing lipopolysaccharides (LPSs) with 
many diol-groups.37-40 The strong (covalent) interactions 
between the boronic acid terminal group of the 
CuONPs/GLYMO/4-HPBA particles and the diol-groups from 
the LPS layer leads to the particle build-up on their cell 
membranes. In contrast, the adhesion of the bare CuONPs to 
the bacterial cell membrane is largely driven by electrostatic 
interactions while the CuONPs/GLYMO/4-HPBA bind to the 
surface saccharides through formation of boronic ester (see 
Figure 1). There are many examples in the literature where this 
effect has been utilized for sensing sugars35,37, 41-42 but to our 
best knowledge this is the first time this idea is applied for 
antibacterial nanoparticle attachment to their targets. Direct 
CFU/mL measurements (see Figure S8 and S9 and Tables S1 
and S2, ESI) also confirm the same trends for the effect of the 
CuONPs/GLYMO/4-HPBA compared to CuONPs for both 
E.coli and R. rhodochrous. Figures S10 and S11 show the 
reduction of the CuONPs/GLYMO/4-HPBA required to 
achieve the same antibacterial effect as CuONPs for these 
bacteria. 
The E.coli samples were sectioned and imaged with SEM and 
TEM as described in the methods section. Figure 8 and Figure 
9 show TEM and SEM images of E. coli cells after incubation 
with CuONPs functionalized with GLYMO and 4-HPBA for up 
to 6 hours. The images clearly show the adherent layer of 
nanoparticles which bind to the bacteria. The result was also 
confirmed via EDX chart of E.coli with CuONPs which 
revealed the presence of Cu on the external part of the E.coli 




Figure 12. The zeta potential of E. coli in aqueous suspensions 
treated with various concentration of (A) bare CuONPs and (B) 
CuONPs/GLYMO/4-HPBA at various exposure times. Error 







Figure 13. Bacterial cell viability after incubation as a function of nanoparticle concentration for 6 hours at various glucose 
concentrations (A and B) E.coli and (C and D) R.rhodochrous. 
 
The occasional build-up of more than one layer of 
CuONPs/GLYMO/4-HPBA particles on the bacteria can also 
be a result of partial particle aggregation before they bind to the 
bacterial cell wall. The zeta-potential of the CuONPs is low by 
magnitude and such partial particle coagulation may take place 
at various stages of the sample preparation. However, the 
CuONPs/GLYMO/4-HPBA particles adhere to the negatively 
charged bacterial cell walls by covalent interactions despite 
their negative zeta potentials as they dominate the weaker 
electrostatic repulsion. We confirmed the result by performing 
EDX on sectioned E. coli and compared between bare CuONPs 
and 4-HPBA functionalized CuONPs which showed presence 
of Cu on the outer part of the cell membrane as 
CuONPs/GLYMO/4-HPBA much higher than the bare 
CuONPs ones as shown in Figure S13. Our results show higher 
Cu concentration on the bacteria outer cell wall for the 
functionalized CuONPs compared with the bare ones. 
Antibacterial Properties of HPBA-Surface 
Functionalized CuONPs on R. rhodochrous. We also tested 
the antibacterial properties of the HPBA-modified CuONPs 
against Gram-positive bacteria. Figure 10 presents the 
antibacterial assay of R. rhodochrous where the control samples 
of untreated bacteria were compared with the ones treated with 
bare CuONPs, CuONPs/GLYMO and CuONPs/GLYMO/4-
HPBA. Note that the cationic bare CuONPs are showing an 
antibacterial effect on R. rhodochrous even at moderate 
CuONPs concentrations (Figure 10B). We discovered that even 
at very low concentrations of CuONPs/GLYMO/4-HPBA they 
are several times more effective against R. rhodochrous 
(Figures 10H and 10I) than the bare CuONPs (Figure 10B and 
10C) and CuONPs/GLYMO (Figure 10E and 10F). A strong 
effect of the bare CuONPs on R. rhodochrous viability was 
observed only after 6 hours of exposure time (Figure 10C). The 
charge of the bare CuONPs is an important factor to interact 
with R. rhodochrous membranes, which contribute to their high 
antibacterial activity. 
Note that for exposure times up to 10 minutes and 1 hour 
(Figure 10D and E), no measurable change in the R. 
rhodochrous viability was detected for CuONPs/GLYMO even 
at high particle concentrations. This also confirms that potential 
release of Cu2+ ions is not the main factor in the antibacterial 
activity of these particles, as CuONPs/GLYMO would support 
the similar concentration of Cu2+ as the bare CuONPs. We also 
did not see a significant difference between the samples kept in 
dark, visible or in UV light conditions at the same 
CuONPs/GLYMO concentration. TEM imaging shows that the 
surfaces of R. rhodochrous cells accumulate a significant 
number of deposited nanoparticles after treatment for 6 hours 
with bare CuONPs (Figure 11B) and CuONPs/GLYMO/4-
HPBA nanocomposites (Figure 11D). In contrast, the untreated 
(Figure 11A) and CuONPs/GLYMO treated R. rhodochrous 
(Figure 11C) show smooth and intact R. rhodochrous cell 
membranes.  
An additional confirmation for the mechanism of attachment of 
the CuONPs/GLYMO/4-HPBA to bacterial cells is presented in 
Figure 12, where we compared the zeta-potential of E. coli after 
being treated with bare CuONPs and CuONPs/GLYMO/4-
HPBA of different particle concentrations. Note that when the 
bacterial cells are treated with bare CuONPs, which are cationic 




absolute value (Figure 12A) due to the partial deposition of the 
cationic CuONPs on the negatively charged bacterial cell wall. 
 
 
Figure 14. HaCaT cell viability after incubation as a function of nanoparticle concentration for up to 36 hours at with bare CuONPs 
and CuONPs/GLYMO/4-HPBA.
 
However, the incubation of the bacterial cells with 
CuONPs/GLYMO/4-HPBA does not incur measurable change 
in their zeta-potential despite their adsorption on the bacterial 
cell wall (Figure 12B). This is an additional confirmation that 
the attachment of the CuONPs/GLYMO/4-HPBA to the 
bacteria is not electrostatic and as Figures 10 and 11 indicate, 
the BA-functionalized CuONPs bind to the bacteria despite 
their negative surface charge. This result is easy to understand 
as the CuONPs/GLYMO/4-HPBA particles are anionic. SEM 
and TEM images (Figures 8 and 9) confirm the particle 
deposition of the E.coli outer membrane. These results suggest 
that the 4-HPBA functional group in the modified 
CuONPs/GLYMO/4-HPBA particles has a significant role in 
promoting adhesion to the R. rhodochrous membranes. The 
strong covalent attachment of the CuONPs/GLYMO/4-HPBA 
with the R. rhodochrous cell membrane is likely to be the main 
contributor towards the bacterial cell membrane disruption and 
damage which makes it a very efficient antibacterial agent. 
Effect of the Presence of Glucose on the Antibacterial 
Activity of HPBA-Functionalized CuONPs towards E.coli 
and R. rhodochrous Figure 13 shows the antibacterial activity 
of the HPBA-surface functionalized CuONPs towards E.coli 
and R. rhodochrous at different concentrations of glucose and 
fixed nanoparticle concentration of 25 µg mL-1. Note that all 
bacteria apparently lost their viability in the presence of bare 
CuONPs after 6 hours independently of the concentration of 
glucose in the solution. However, the bacteria viability in the 
presence of CuONPs/GLYMO/4-HPBA increased with 
increasing of the glucose concentration. A possible mechanism 
for this could be that in the presence of glucose the boronic acid 
functional groups of the CuONPs/GLYMO/4-HPBA 
nanoparticles bind to the free glucose in solution thus reducing 
the interaction between 4-HPBA terminal group and the 
bacterial membranes. This also confirms that the mechanism of 
attachment of the CuONPs/GLYMO/4-HPBA to the bacteria is 
based on binding to sugar groups. 
Cytotoxicity of Bare and HPBA-Functionalized CuONPs 
on Human Keratinocytes. Figure 14 shows the cytotoxicity 
assay of CuONPs and CuONPs/GLYMO/HPBA on HaCaT 
cells for up to several hours of exposure. The results confirm 
that CuONPs/GLYMO/HPBA have negligible toxic effect on 
these cells while bare CuONPs have some low level of toxicity 
compared with the control sample. These results are obtained 
with particle concentrations where they are showing very strong 
antibacterial effect on E.coli and R. rhodochrous while leaving 
the keratinocyte cells unaffected. We took SEM images of 
dehydrated HaCaT cells after being treated with bare and 
HPBA-functionalized CuONPs and compared them with SEM 
images of the control ssample (no treatment). The results are 
presented in Figure S12. In both cases, we did not observe 
significantly different build-up of CuONPs on these images 
which does not allow directly to differentiate the mechanism of 
their potential cytotoxic action on keratinocytes. One possible 
explanation why the skin cells are unaffected by both the bare 
and the functionalized CuONPs could be that their membrane 
is easier to bend around the adhering rough nanoparticles and is 
less prone to dislocation and rupture than the rigid membranes 
of bacteria.6 This result is reassuring that such antimicrobial 
particles can potentially find application in wound care 
formulations as an alternative to antimicrobial delivery 
vehicles.43,44 
CONCLUSIONS 
In summary, we have developed a novel type of modified 
CuONPs which have been functionalized with GLYMO and 4-
HPBA (CuONPs/GLYMO/4-HPBA) to produce an 
antibacterial agent of much higher efficiency than bare 




allows the antimicrobial particles to form covalent bonds with 
the diol groups from carbohydrates expressed on the cell wall 
of both Gram-positive and Gram–negative bacteria. We 
demonstrate the profound differences in the surface properties 
of the bare CuONPs and the CuONPs/GLYMO/4-HPBA 
particles which at neutral pH have different surface charge. The 
zeta potential of non-functionalized CuONPs, GLYMO-
functionalized CuONPs and 4-HPBA-functionalized CuONPs 
was +37 mV, -3 mV and -10 mV, respectively. It was found that 
both nanoparticles showed opposite surface charge in the 
aqueous solution at pH 6 as their zeta potential decreased from 
+37 mV to -10 mV. Our antibacterial assays showed that the 
anionic nanoparticles as CuONPs/GLYMO/4-HPBA have 
much higher antibacterial action than the cationic ones non-
functionalized CuONPs for both Gram-positive and Gram-
negative bacteria. This is explained by the strong adhesion of 
the anionic particles CuONPs/GLYMO/4-HPBA to the cell 
walls due to their covalent interactions between the terminal 4-
Hydroxyphenylboronic acid group and carbohydrates on the 
cell surface. SEM and TEM images of R. rhodochrous and 
E.coli exposed to 4-HPBA functionalized CuONPs confirmed 
the formation of a significant build-up of these nanoparticles on 
the bacterial cell outer membrane. Control experiments proved 
that the binding ability of the modified CuONPs/GLYMO/4-
HPBA to bacteria can be adjusted and reversed by adding 
glucose in the media which engages the boronic acid groups of 
the CuONPs surface and lessens their ability to attach to 
bacteria. This effect allows direct control over their 
antimicrobial action. Preliminary experiments of incubation of 
the HPBA-functionalized CuONPs with human keratinocytes 
showed no measurable cytotoxicity.   In general, we envisage 
that this type of functionality can be successfully applied to a 
range of inorganic nanoparticles, as ZnONPs, TiO2NPs, 
Ag2ONPs, Cu2ONPs and others which would lead to fabrication 
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